コンテンツへスキップ
Merck
  • Filovirus Antiviral Activity of Cationic Amphiphilic Drugs Is Associated with Lipophilicity and Ability To Induce Phospholipidosis.

Filovirus Antiviral Activity of Cationic Amphiphilic Drugs Is Associated with Lipophilicity and Ability To Induce Phospholipidosis.

Antimicrobial agents and chemotherapy (2020-06-10)
Antonia P Gunesch, Francisco J Zapatero-Belinchón, Lukas Pinkert, Eike Steinmann, Michael P Manns, Gisbert Schneider, Thomas Pietschmann, Mark Brönstrup, Thomas von Hahn
要旨

Several cationic amphiphilic drugs (CADs) have been found to inhibit cell entry of filoviruses and other enveloped viruses. Structurally unrelated CADs may have antiviral activity, yet the underlying common mechanism and structure-activity relationship are incompletely understood. We aimed to understand how widespread antiviral activity is among CADs and which structural and physico-chemical properties are linked to entry inhibition. We measured inhibition of Marburg virus pseudoparticle (MARVpp) cell entry by 45 heterogeneous and mostly FDA-approved CADs and cytotoxicity in EA.hy926 cells. We analyzed correlation of antiviral activity with four chemical properties: pKa, hydrophobicity (octanol/water partitioning coefficient; ClogP), molecular weight, and distance between the basic group and hydrophobic ring structures. Additionally, we quantified drug-induced phospholipidosis (DIPL) of a CAD subset by flow cytometry. Structurally similar compounds (derivatives) and those with similar chemical properties but unrelated structures (analogues) to those of strong inhibitors were obtained by two in silico similarity search approaches and tested for antiviral activity. Overall, 11 out of 45 (24%) CADs inhibited MARVpp by 40% or more. The strongest antiviral compounds were dronedarone, triparanol, and quinacrine. Structure-activity relationship studies revealed highly significant correlations between antiviral activity, hydrophobicity (ClogP > 4), and DIPL. Moreover, pKa and intramolecular distance between hydrophobic and hydrophilic moieties correlated with antiviral activity but to a lesser extent. We also showed that in contrast to analogues, derivatives had antiviral activity similar to that of the seed compound dronedarone. Overall, one-quarter of CADs inhibit MARVpp entry in vitro, and antiviral activity of CADs mostly relies on their hydrophobicity yet is promoted by the individual structure.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
(±)-プロプラノロール 塩酸塩, ≥99% (TLC), powder
Sigma-Aldrich
キナクリン 二塩酸塩, ≥90%
Sigma-Aldrich
プロメタジン 塩酸塩
Sigma-Aldrich
テイコプラニン
Sigma-Aldrich
チオリダジン 塩酸塩, ≥99%
Sigma-Aldrich
ミアンセリン 塩酸塩
Sigma-Aldrich
(+)-フェンフルラミン 塩酸塩
Sigma-Aldrich
イミプラミン 塩酸塩, BioXtra, ≥99% (TLC)
Sigma-Aldrich
プロクロルペラジン 二マレイン酸塩
Sigma-Aldrich
U 18666A, powder
Sigma-Aldrich
Gentamicin 硫酸, meets USP testing specifications, powder
Sigma-Aldrich
ドロネダロン 塩酸塩, ≥98% (HPLC)
Sigma-Aldrich
マプロチリン 塩酸塩, >99% (HPLC), powder
Sigma-Aldrich
ジメリジン 二塩酸塩, solid
Supelco
トリペレナミン 塩酸塩, analytical standard
Sigma-Aldrich
N-(6-Aminohexyl)-1-naphthalenesulfonamide hydrochloride, ≥98% (HPLC)
Sigma-Aldrich
トリフルオペラジン 塩酸塩, meets USP testing specifications
フルペンチキソール 二塩酸塩, European Pharmacopoeia (EP) Reference Standard